Clinical Trial Update: Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain [Phase 3]

View source ↗

Summary

Phase 3 long-term safety data from a trial evaluating an opioid-induced constipation treatment in patients with persistent non-cancer pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• Opioid-induced constipation treatment (unknown specific agent)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Bowel Dysfunction, Constipation | Phase 3 | Status: COMPLETED